Early Onset Diabetes Shortens Lifespan by Years
By HospiMedica International staff writers Posted on 23 Aug 2018 |
A new study reveals that women who develop type 1 diabetes (T1D) before the age of 10 years die an average of nearly 18 years earlier than women who do not have diabetes.
Researchers at Sahlgrenska Academy (SA; Göteborg, Sweden), the University of Gothenburg (Sweden), the Swedish National Diabetes Register, and other institutions conducted a Swedish nationwide, register-based cohort study involving 27,195 people with T1D and 135,178 matched controls in order to stratify age of onset as a risk factor. Study participants were categorized into five groups, according to age at diagnosis: 0–10 years, 11–15 years, 16–20 years, 21–25 years and 26–30 years. During the median follow-up period of 10 years, 959 T1D participants and 1,501 controls died.
The researcher analyzed the data in order to estimate excess risk of all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, acute myocardial infarction (MI), stroke, cardiovascular disease (a composite of acute myocardial infarction and stroke), coronary heart disease, heart failure (HF) and atrial fibrillation (AF). The results revealed that age at onset of T1D is an important determinant of survival and cardiovascular outcomes, with highest excess risk observed in women.
The probability of severe cardiovascular disease proved to be 30 times higher for those who developed T1D before the age of 10 years than for controls. The highest increase in mortality risk involved heart attacks in women who developed T1D before the age of ten, 90 times higher than that of the controls, shortening their life by an average of 17.7 years. Men with T1D in the corresponding situation lost 14.2 years of life. Diagnosis of T1D at 26-30 years resulted in a corresponding risk increase by a factor of six, or 10 years of life. The study was published on August 11, 2018, in The Lancet.
“These are disappointing and previously unknown figures. The study suggests that we must make an even greater effort to aggressively treat patients diagnosed at an early age to reduce the risk of complications and premature death,” said lead author Araz Rawshani, PhD, of Sahlgrenska Academy. “At the same time, the study must also be viewed in the light of the tremendous progress that has been made in the past few decades. Those who live with diabetes today, and those who will acquire the disease, will enjoy longer and healthier lives in the years to come.”
T1D is an autoimmune disease in which a person's pancreas stops producing insulin. It can impact both children and adults at any age, causing dependence on multiple daily injections of insulin or an insulin pump. Serious short and long term complications stemming from high blood sugar levels can lead to kidney failure, blindness, nerve damage, heart attack, and stroke. Low levels can be life-threatening, particularly at night when they are most difficult to manage.
Related Links:
Sahlgrenska Academy
University of Gothenburg
Researchers at Sahlgrenska Academy (SA; Göteborg, Sweden), the University of Gothenburg (Sweden), the Swedish National Diabetes Register, and other institutions conducted a Swedish nationwide, register-based cohort study involving 27,195 people with T1D and 135,178 matched controls in order to stratify age of onset as a risk factor. Study participants were categorized into five groups, according to age at diagnosis: 0–10 years, 11–15 years, 16–20 years, 21–25 years and 26–30 years. During the median follow-up period of 10 years, 959 T1D participants and 1,501 controls died.
The researcher analyzed the data in order to estimate excess risk of all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, acute myocardial infarction (MI), stroke, cardiovascular disease (a composite of acute myocardial infarction and stroke), coronary heart disease, heart failure (HF) and atrial fibrillation (AF). The results revealed that age at onset of T1D is an important determinant of survival and cardiovascular outcomes, with highest excess risk observed in women.
The probability of severe cardiovascular disease proved to be 30 times higher for those who developed T1D before the age of 10 years than for controls. The highest increase in mortality risk involved heart attacks in women who developed T1D before the age of ten, 90 times higher than that of the controls, shortening their life by an average of 17.7 years. Men with T1D in the corresponding situation lost 14.2 years of life. Diagnosis of T1D at 26-30 years resulted in a corresponding risk increase by a factor of six, or 10 years of life. The study was published on August 11, 2018, in The Lancet.
“These are disappointing and previously unknown figures. The study suggests that we must make an even greater effort to aggressively treat patients diagnosed at an early age to reduce the risk of complications and premature death,” said lead author Araz Rawshani, PhD, of Sahlgrenska Academy. “At the same time, the study must also be viewed in the light of the tremendous progress that has been made in the past few decades. Those who live with diabetes today, and those who will acquire the disease, will enjoy longer and healthier lives in the years to come.”
T1D is an autoimmune disease in which a person's pancreas stops producing insulin. It can impact both children and adults at any age, causing dependence on multiple daily injections of insulin or an insulin pump. Serious short and long term complications stemming from high blood sugar levels can lead to kidney failure, blindness, nerve damage, heart attack, and stroke. Low levels can be life-threatening, particularly at night when they are most difficult to manage.
Related Links:
Sahlgrenska Academy
University of Gothenburg
Latest Patient Care News
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
- World's First AI-Ready Infrasound Stethoscope Listens to Bodily Sounds Not Audible to Human Ear
- POC Diagnostic Platform Offers Handheld, Instrument-Free PCR Testing for STIs
Channels
Artificial Intelligence
view channel
AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation
Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib... Read more
AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors
Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves.... Read moreCritical Care
view channel
Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
Atrial fibrillation, the most common type of cardiac arrhythmia worldwide, affected approximately 59 million people in 2019. Characterized by an irregular and often rapid heart rate, atrial fibrillation... Read more
Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
The peripheral nervous system (PNS) serves as the communication network that links the brain and spinal cord to every other part of the body. It consists of two parts: the somatic nervous system, which... Read moreSurgical Techniques
view channel
Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more
Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
The physical strain associated with the static postures maintained by neurosurgeons during long operations can lead to fatigue and musculoskeletal problems. An objective assessment of surgical ergonomics... Read more.jpg)
Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
The evolving field of 3D printing is revolutionizing orthopedics, especially for individuals requiring joint replacement surgeries where traditional implants fail to provide a solution. Although most people... Read more
Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read moreHealth IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Point of Care HIV Test Enables Early Infection Diagnosis for Infants
Early diagnosis and initiation of treatment are crucial for the survival of infants infected with HIV (human immunodeficiency virus). Without treatment, approximately 50% of infants who acquire HIV during... Read more
Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked.... Read more
New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and... Read moreBusiness
view channel
Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
Johnson & Johnson (New Brunswick, N.J., USA) and Shockwave Medical (Santa Clara, CA, USA) have entered into a definitive agreement under which Johnson & Johnson will acquire all of Shockwave’s... Read more